Two organizations have successfully gained breakthrough therapy designation for psilocybin, paving the way for potential FDA approval. The focus is on psychotherapy assisted by these substances, with trained therapists guiding patients through their experiences. Clinics will offer a range of psychedelic treatments, allowing for personalized care tailored to individual needs and circumstances.
